Literature DB >> 12062737

Side effects of statins: hepatitis versus "transaminitis"-myositis versus "CPKitis".

Carlos A Dujovne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062737     DOI: 10.1016/s0002-9149(02)02356-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  17 in total

1.  Monitoring drug treatment.

Authors:  Munir Pirmohamed; Robin E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 2.  Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Authors:  Rossana M Calderon; Luigi X Cubeddu; Ronald B Goldberg; Eugene R Schiff
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

3.  Statin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman.

Authors:  Jimmy Jose; Faisal Abdullah Ali Al-Tamimi; Manal Mahmoud Helal; Beena Jimmy; Qasim Al Riyami
Journal:  Oman Med J       Date:  2014-09

Review 4.  What combination therapy with a statin, if any, would you recommend?

Authors:  Carlos A Dujovne; Craig D Williams; Matthew K Ito
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 5.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

6.  Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia?

Authors:  Maureen E Mays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

Review 7.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 8.  Molecular targets of statins and their potential side effects: Not all the glitter is gold.

Authors:  Kush K Patel; Viren S Sehgal; Khosrow Kashfi
Journal:  Eur J Pharmacol       Date:  2022-03-20       Impact factor: 4.432

9.  Molecular mechanisms of statin intolerance.

Authors:  Anna Gluba-Brzozka; Beata Franczyk; Peter P Toth; Jacek Rysz; Maciej Banach
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

Review 10.  Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.

Authors:  Enas A Enas; Arun Kuruvila; Pravien Khanna; C S Pitchumoni; Viswanathan Mohan
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.